Loading company…
Shanghai-based biotech firm providing contract research, drug discovery and contract manufacturing services for drug development.
Founded in 2008 and based in Shanghai, Viva Biotech (Shanghai) Ltd. provides Contract Research Organization (CRO) drug discovery services and Contract Manufacturing and Development Organization (CDMO) services across the drug production process. The company was listed on the Hong Kong Stock Exchange under the number 01873 in May 2019 and had served 1,820 biotech and pharmaceutical clients as of December 31, 2021. In June 2023, HighLight Capital, Temasek Holdings and Truelight Capital agreed to invest USD 150 million in the company. Its 2022 revenue and net income were CNY 2.379 billion and CNY -504.22 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in